Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity
Yi-Wei Liu(St. Jude Children's Research Hospital), Mary V. Relling(St. Jude Children's Research Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), William E. Evans(St. Jude Children's Research Hospital), Wenjian Yang(St. Jude Children's Research Hospital), Sima Jeha(St. Jude Children's Research Hospital), Naomi Winick(The University of Texas Southwestern Medical Center), Jun J. Yang(St. Jude Children's Research Hospital), Kimberly P. Dunsmore(University of Virginia), Ching‐Hon Pui(American Cancer Society), Stuart S. Winter(New Mexico Cancer Center), Hiroto Inaba(St. Jude Children's Research Hospital), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Cheng Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Seth E. Karol(St. Jude Children's Research Hospital), Colton A. Smith(St. Jude Children's Research Hospital), Mignon L. Loh(Seattle Children's Hospital)
Cited by 13
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k